Dr Oliver Rivero-Arias
+44 (0)1865 617908
Jenny Shilton Osborne
Associate Professor of Health Economics
- Senior Health Economist at NPEU
Oliver joined the National Perinatal Epidemiology Unit (NPEU) as the Senior Health Economist in November 2013 working previously at the Health Economics Research Centre (HERC) during the period 2002-2013. He currently leads a team of health economists involved in a programme of work conducting economic evaluations and stated-preference studies in maternal and child health. He has extensive experience using experimental and observational data, and evidence synthesis decision analytic models to inform cost-effectiveness evaluations. His programme of work also includes studies estimating the long-term healthcare costs of prematurity and the long-term health care costs of women and their babies after successful fertility treatment. Oliver is interested in the valuation of health for decision-making and he has undertaken a series of studies to understand how to value children's health for resource allocation. He is actively involved in teaching and postgraduate supervision and sits in panels for the UK National Screening Programme and the National Institute for Health Research Fellowships. He is a co-editor-in-chief of the academic journal Health and Quality of Life Outcomes.
Neonatal health care costs of very preterm babies in England: a retrospective analysis of a national birth cohort
Yang M. et al, (2023), BMJ Paediatrics Open
Gestational age and hospital admission costs from birth to childhood: a population-based record linkage study in England.
Hua X. et al, (2023), Arch Dis Child Fetal Neonatal Ed
Benefits and harms of antenatal and newborn screening programmes in health economic assessments: the VALENTIA systematic review and qualitative investigation
RIVERO ARIAS O. et al, (2023), Health Technology Assessment
The Use of Multi-Criteria Decision Analysis (MCDA) to Support Decision-Making in Healthcare: an Updated Systematic Literature Review.
Gongora-Salazar P. et al, (2022), Value Health
Analytical considerations when anchoring discrete choice experiment values using composite time trade-off data: the case of EQ-5D-Y-3L
Mott DJ. et al, (2022), PharmacoEconomics